Amneal Pharmaceuticals Inc (AMRX)
14.58
-0.55%
Amneal Pharmaceuticals Inc (AMRX) is currently trading at $14.58. This represents a loss of 0.55% from the previous session. With a market capitalization of $4.58B, AMRX is a key component of the Health Care sector. Investors looking to trade AMRX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade AMRX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Amneal Pharmaceuticals Inc (AMRX) shows a bearish trend. Analysts are watching the 14.84 level closely.
Fundamentals
Mkt Cap4.58B
P/E Ratio0.0000
Volume1,545,419
60-Day Technical Chart
Advanced Charting
Need more indicators for AMRX? Use the world's #1 platform.
Open AMRX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $15
| Metric |
AMRX -0.55% |
F +1.62% |
AAL +1.29% |
HIMS +2.33% |
|---|---|---|---|---|
| Price | $14.58 | $14.43 | $13.32 | $15.82 |
| Mkt Cap | $4.58B | $57.57B | $8.80B | $3.61B |
| - | View → | View → | View → |
Latest Headlines
Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now?
Yahoo Finance • Feb 23, 2026
Amneal Pharmaceuticals, Inc. (AMRX) Added to S&P SmallCap 600 Index, Boosting Investor Visibility
Finviz • Feb 18, 2026
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026
GlobeNewswire • Jan 27, 2026
Amneal (Nasdaq: AMRX) gains FDA OK for epinephrine vials in $118M U.S. market
Stock Titan • Dec 9, 2025
Is Amneal Pharmaceuticals (AMRX) a Great Value Stock Right Now?
Yahoo Finance • Feb 5, 2026
● Gemini Agentic AI Analyst Insight for AMRX
Market Education
- 🔥 Top 7 AI Penny Stocks That Could Explode in 2025 Nov 16, 2025
- I don't get this Dollar Cost Averaging (DCA). Explain pls Jul 18, 2023
- October Market Volatility: Why Investors Fear the “Danger Month” Sep 26, 2025
External Research